Bank of Montreal’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-1,126
Closed -$70K – 4152
2022
Q1
$70K Buy
+1,126
New +$80.7K ﹤0.01% 3727
2021
Q4
– Sell
-5,898
Closed -$1.01M – 3559
2021
Q3
$1.01M Buy
+5,898
New +$958K ﹤0.01% 2487
2021
Q2
– Sell
-85
Closed -$15K – 3947
2021
Q1
$15K Sell
85
-260
-75% -$49.6K ﹤0.01% 4174
2020
Q4
$62K Buy
345
+224
+185% +$37.5K ﹤0.01% 3838
2020
Q3
$19K Sell
121
-43
-26% -$7.76K ﹤0.01% 3856
2020
Q2
$33K Buy
164
+138
+531% +$25.3K ﹤0.01% 3620
2020
Q1
$4K Sell
26
-198
-88% -$20K ﹤0.01% 3711
2019
Q4
$17K Buy
224
+90
+67% +$7.85K ﹤0.01% 4383
2019
Q3
$14K Buy
134
+8
+6% +$931 ﹤0.01% 4263
2019
Q2
$17K Buy
+126
New +$17.3K ﹤0.01% 4261
2019
Q1
– Sell
-22
Closed -$4K – 4392
2018
Q4
$4K Sell
22
-12
-35% -$2.38K ﹤0.01% 4146
2018
Q3
$9K Buy
34
+24
+240% +$6.02K ﹤0.01% 3945
2018
Q2
$2K Buy
+10
New +$1.89K ﹤0.01% 4335
2016
Q1
– Sell
-1,370
Closed -$153K – 4217
2015
Q4
$153K Buy
+1,370
New +$187K ﹤0.01% 2567

Other funds holding CTSO

Bank of Montreal's CTSO Position: Q2 2022 in Review

Bank of Montreal sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 1,126 shares — an estimated $70K sold.

Bank of Montreal first reported a position in CTSO in Q4 2015 and held it in 14 quarters. The position peaked at $1.01M in Q3 2021. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

  • Bank of Montreal reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 1,126 Cytosorbents Corp shares in Q2 2022, an estimated $70K.
  • Bank of Montreal first reported a position in Cytosorbents Corp in Q4 2015 and held it in 14 quarters.
  • Bank of Montreal's Cytosorbents Corp position peaked at $1.01M in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.